A phase II/III extension study to evaluate the safety and tolerability of atrasentan

Trial Profile

A phase II/III extension study to evaluate the safety and tolerability of atrasentan

Completed
Phase of Trial: Phase II/III

Latest Information Update: 28 Nov 2007

At a glance

  • Drugs Atrasentan (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 28 Nov 2007 Status changed from in progress to completed.
    • 09 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top